The genomic and pathologic data generated here support predominant adenocarcinoma-to-SCLC plasticity in this subset and its association with EGFR mutations and APOBEC mutagenesis and contrast this pathway with carcinoid-to-SCLC plasticity associated with chromothripsis in aSCLC. The gene discussed is EGFR; the disease is carcinoid tumor.